Lower blood pressure targets and brain white matter lesions

Intensive blood pressure treatment was linked to a smaller increase in white matter lesion volume.

Intensive treatment for systolic blood pressure was associated with a reduction in the accrual of cerebral white matter lesion volume. No statistically significant difference was observed in the incidence of a composite of all cause dementia or mild cognitive impairment.

Researchers studied 12,821 adults aged ≥\ge50 years with type 2 diabetes and raised systolic blood pressure (SBP). Participants were randomly assigned to intensive treatment targeting SBP <120 mm Hg or standard treatment targeting SBP <140 mm Hg for up to five years.

Systolic blood pressure (SBP) is a measure of blood pressure. Dementia is a cognitive outcome. Mild cognitive impairment is a cognitive outcome. White matter lesion volume refers to changes in brain magnetic resonance imaging (MRI) characteristics.

The intensive treatment group had 747 participants with the primary cognitive outcome. This was 3.69 events per 100 person years. The standard treatment group had 783 participants with the primary cognitive outcome, or 3.89 events per 100 person years.

In the MRI substudy, the intensive treatment group had a smaller increase in white matter lesion volume compared with the standard treatment group. The difference between groups was -0.09 inverse hyperbolic sine (asinh) transformed cm3\text{cm}^3, with a 95% confidence interval (CI) of -0.15 to -0.02 and a P value of 0.01.

Key facts

  • Intensive treatment targeted SBP <120 mm Hg while standard treatment targeted SBP <140 mm Hg.
  • Intensive treatment was associated with a reduction in the accrual of cerebral white matter lesion volume.
  • No statistically significant difference was observed in the incidence of all cause dementia or mild cognitive impairment.

All sections

Edition